MedTrace Logo

Prospective on Market Patient-reported Outcomes for Milli

NCT06397885 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2024-11-20

No results posted yet for this study

Summary

To assess the effectiveness of the Milli device in achieving vaginal intercourse

Conditions

  • Vaginismus
  • Dyspareunia

Interventions

DEVICE

Milli Vaginal Dilator

Patient-controlled vaginal dilator that provides therapy through distention of the vaginal tissue under electromechanical expansion

Sponsors & Collaborators

  • Materna Medical

    lead INDUSTRY

Principal Investigators

  • Sheryl Kingsberg, Ph.D · Materna Clinic

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-12
Primary Completion
2025-11-30
Completion
2025-12-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06397885 on ClinicalTrials.gov